TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers

On November 17, 2015, TheGrantLawFirm, PLLC disseminated a notice to shareholders under the PSLRA, announcing that it filed a class action complaint (“Complaint”) on behalf of all securities holders who purchased securities of Spectrum Pharmaceuticals, Inc. (SPPI: NASDAQ)(“Spectrum” or the “Company”) during the period between May 7, 2015 until October 23, 2015, inclusive (the “Class Period”). Since the publication of the PSLRA notice, TheGrantLawFirm, PPLC has withdrawn the complaint.

Contacts:

TheGrantLawFirm, PLLC
Lynda J. Grant, Esq.
Telephone: 212-292-4441
Facsimile: 212-292-4446
lgrant@grantfirm.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.